Skip to content

CT Diagnoses in Crohns Disease Activity

Applications of CT in Differentiating Crohn's Disease Activity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04956991
Enrollment
35
Registered
2021-07-09
Start date
2011-06-01
Completion date
2017-12-30
Last updated
2021-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease

Brief summary

The study focused on the clinical value of CT in assessing the activity of Crohn's disease.

Detailed description

Crohn's disease is an inflammatory disease with non-specific clinical manifestations. The lesions are more common in the ileocecal area and the end of the ileum, and also can affect the entire digestive tract. In recent years, the domestic incidence of Crohn's disease has been increasing. At present, CT diagnosis still lacks the gold standard and requirescombination of clinical manifestations, endoscopic examination, imaging examination and laboratory examination results. CT has showed advantages of non-invasive inspection, fast imaging speed, high tissue density resolution, and strong patient acceptability. In addition, the examination can clearly show the internal and external tissue structure of the digestive tract, which has been widely used in the diagnosis and activity evaluation of Crohn's disease. In order to clarify the clinical value of CT in assessing the activity of Crohn's disease, this study mainly used retrospective analysis of the CT manifestations and clinical data of patients with Crohn's disease to explore the clinical value of CT in assessing the activity of patients with Crohn's disease.

Interventions

None listed

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Crohn's disease patients with confirmed endoscopic or pathological examination results * Complete laboratory data such as CRP, erythrocyte sedimentation rate, etc.

Exclusion criteria

* Related inspection results are not complete * The interval between endoscopic and laboratory examination results exceeds 2 months

Design outcomes

Primary

MeasureTime frameDescription
Crohn's disease activity index (CDAI) scores1yearCrohn's disease activity index (CDAI) scores

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026